Meeting
2016 ASCO Annual Meeting
Concurrent genetic alterations identified by next-generation sequencing in pre-treatment, metastatic EGFR-mutant lung cancers.
Authors
Helena Alexandra Yu
Memorial Sloan Kettering Cancer Center, New York, NY
Helena Alexandra Yu , Emmet Jordan , Ai Ni , Daniel Feldman , Christopher Rodriguez , Hyunjae Ryan Kim , Mark G. Kris , David B. Solit , Michael F. Berger , Marc Ladanyi , Maria E. Arcila , Gregory J. Riely
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 9053)
DOI
10.1200/JCO.2016.34.15_suppl.9053
Abstract #
9053
Poster Bd #
376
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Identification of pretreatment genomic biomarkers and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers.
First Author: Noura J. Choudhury
Poster
2021 ASCO Annual Meeting
Targeted ctDNA sequencing analysis reveals concurrent genomic alterations and its impact on TKI and immune checkpoint inhibitor therapy in advanced NSCLC from Asian population.
First Author: Wei Wu
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Molecular genetic sequencing of neuroendocrine tumors of the gastrointestinal tract.
First Author: Alexandra Androsova
First Author: Neal A. Fischbach